Cancer is one of the leading causes of death in the U.S., and is expected to be the number one killer in 16 years. Men are more likely to die of cancer than women, but scientific advancements like antibiotics, vaccines, and chemotherapy have decreased how often people die of cancer. Prostate cancer is the leading cancer for males, but there are other cancers men should protect themselves against as well. Prostate cancer is the number one cancer risk for men, and the number two cancer killer (after lung cancer). About one man in seven will be diagnosed with prostate cancer during his lifetime, according to the American Cancer Society.
Ever since 1761, when the Italian physician Giovanni Battista Morgagni published his detailed findings from 700 autopsies, cancers have been inextricably linked with the organs they inhabit. Over the next 250 years, physicians would learn that even after a tumor had been fully excised from one organ, some remnant of the malignancy could spread to other organs through fluids like blood and lymph. With the advent of microscopes in the late 19th century, they would begin to appreciate tumors' commonalities and differences in cellular detail. And with the decoding of the human genome, they would begin to discern the roles that DNA mutations play in helping cancers begin, grow and spread. Through it all, doctors have organized their notions of cancer according to that fundamental principle of real estate: location, location, location.
A study released by the American Cancer Society (ACS) Tuesday shows a steady rise in colorectal cancer (also known as colon cancer) among young people, according to NBC News. Colon cancer has seen a decline in reported cases overall, but reasons for a rise among young white individuals remain unknown to researchers. The study claims that reported cases have increased by 1.6 percent annually in adults younger than 50. This finding can be traced back to 2004, which is when the first spike in colon cancer among individuals under 54 reportedly occurred. However, the study adds, "the increase in young adults followed a decade of rapid declines during the late 1970s and early 1980s."
A new type of cancer drug that wakes up the patient's own immune system to fight tumours could be a game changer for tackling aggressive head and neck cancers, say experts. Trial results coming out of a US cancer conference suggest the treatment works better than standard chemotherapy. Nivolumab significantly improved the survival odds of patients with these hard-to-treat tumours. It is already available on the NHS for people with advanced skin cancer. But experts say more research is needed before offering it routinely to patients with other cancers.
Fighter, warrior, hero - some of the terms you might see used to describe people with cancer. But according to a new survey, for some with the illness the words are seen as inappropriate rather than uplifting. The UK poll by Macmillan Cancer Support of 2,000 people who have or had cancer found "cancer-stricken" and "victim" were also among the least-liked terms. The charity said it showed how "divisive" simple descriptions of cancer can be. Calling a person's cancer diagnosis a "war" or a "battle" and saying they had "lost their battle" or "lost their fight" when they died, were other unpopular descriptions, according to the poll carried out by YouGov.